Alginate as a potential diphase solid dispersion carrier with enhanced drug dissolution and improved storage stability

European Journal of Pharmaceutical Sciences

Volumn 114, Issue , 2018, Pages 346-355

  Guan, Jian ^a   Liu, Qiaoyu ^a   Zhang, Xiaofei ^a   Zhang, Yeli ^b   Chokshi, Rina ^b   Wu, Haiyang ^a   Mao, Shirui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b FMC CORPORATION   (United States)

Author keywords

Alginate; Hansen solubility parameter; Miscibility; Raman mapping; Solid dispersion; Stability

Indexed keywords

ALGINIC ACID; DRUG CARRIER; INDOMETACIN; MEVINOLIN; GLUCURONIC ACID; HEXURONIC ACID;

ARTICLE; DISPERSION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HYDROGEN BOND; IN VITRO STUDY; MISCIBILITY; PHASE SEPARATION; PRIORITY JOURNAL; CHEMISTRY; METABOLISM; SOLUBILITY;

ALGINATES; DRUG CARRIERS; DRUG LIBERATION; DRUG STABILITY; DRUG STORAGE; GLUCURONIC ACID; HEXURONIC ACIDS; INDOMETHACIN; LOVASTATIN; SOLUBILITY;

EID: 85040017295     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2017.12.028     Document Type: Article

References (30)

1. Borba, Amarante P.A., Pinotti, M., Maduro de Campos, C.E., Pezzini, B.R., Stulzer, H.K., Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs. Carbohydr. Polym. 137 (2016), 350–359.
2. Craig, D.Q.M., The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231:2002 (2002), 131–144.
3. Devi, N., Kakati, D.K., Smart porous microparticles based on gelatin/sodium alginate polyelectrolyte complex. J. Food Eng. 117 (2013), 193–204.
4. Fahr, A., Liu, X., Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Deliv. 4 (2007), 403–416.
5. Friesen, D.T., Shanker, R., Crew, M., Smithey, D.T., Curatolo, W.J., Nightingale, J.A.S., Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol. Pharm. 5 (2008), 1003–1019.
6. George, M., Abraham, T.E., Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review. J. Control. Release 114 (2006), 1–14.
7. Guan, J., Zhang, Y., Liu, Q., Zhang, X., Chokshi, R., Mao, S., Exploration of alginates as potential stabilizers of nanosuspension. AAPS PharmSciTech 18 (2017), 3172–3181.
8. Keck, C.M., Muller, R.H., Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm. 62 (2006), 3–16.
9. Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J.T., Kim, H., Cho, J.M., Yun, G., Lee, J., Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J. Pharm. Sci. 9 (2014), 304–316.
10. Knopp, M.M., Nguyen, J.H., Becker, C., Francke, N.M., Jorgensen, E.B., Holm, P., Holm, R., Mu, H.L., Rades, T., Langguth, P., Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions. Eur. J. Pharm. Biopharm. 101 (2016), 145–151.
11. Li, L., Wang, L.L., Shao, Y., Ni, R., Zhang, T.T., Mao, S.R., Drug release characteristics from chitosan-alginate matrix tablets based on the theory of self-assembled film. Int. J. Pharm. 450 (2013), 197–207.
12. Liew, C.V., Chan, L.W., Ching, A.L., Heng, P.W.S., Evaluation of sodium alginate as drug release modifier in matrix tablets. Int. J. Pharm. 309 (2006), 25–37.
13. Lombardino, J.G., Lowe, J.A., The role of the medicinal chemist in drug discovery - then and now. Nat. Rev. Drug Discov. 3 (2004), 853–862.
14. Marsac, P.J., Shamblin, S.L., Taylor, L.S., Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm. Res. 23 (2006), 2417–2426.
15. Matsumoto, T., Zografi, G., Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm. Res. 16 (1999), 1722–1728.
16. Mehta, M., Kothari, K., Ragoonanan, V., Suryanarayanan, R., Effect of water on molecular mobility and physical stability of amorphous pharmaceuticals. Mol. Pharm. 13 (2016), 1339–1346.
17. de Mohac, L.M., Pina, M.D., Raimi-Abraham, B.T., Solid microcrystalline dispersion films as a new strategy to improve the dissolution rate of poorly water soluble drugs: a case study using olanzapine. Int. J. Pharm. 508 (2016), 42–50.
18. Obeidat, W.M., Sallam, A.A., Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties. AAPS PharmSciTech 15 (2014), 364–374.
19. Onoue, S., Takahashi, H., Kawabata, Y., Seto, Y., Hatanaka, J., Timmermann, B., Yamada, S., Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J. Pharm. Sci. 99 (2010), 1871–1881.
20. Parikh, T., Sandhu, H.K., Talele, T.T., Serajuddin, A.T.M., Characterization of solid dispersion of itraconazole prepared by solubilization in concentrated aqueous solutions of weak organic acids and drying. Pharm. Res. 33 (2016), 1456–1471.
21. Penumetcha, S.S., Gutta, L.N., Dhanala, H., Yamili, S., Challa, S., Rudraraju, S., Rudraraju, V., Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study. Drug Dev. Ind. Pharm. 42 (2016), 1609–1620.
22. Phang, Y.N., Chee, S.Y., Lee, C.O., Teh, Y.L., Thermal and microbial degradation of alginate-based superabsorbent polymer. Polym. Degrad. Stab. 96 (2011), 1653–1661.
23. Qian, F., Huang, J., Hussain, M.A., Drug-polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development. J. Pharm. Sci. 99 (2010), 2941–2947.
24. Raimi-Abraham, B.T., Mahalingam, S., Davies, P.J., Edirisinghe, M., Craig, D.Q.M., Development and characterization of amorphous nanofiber drug dispersions prepared using pressurized gyration. Mol. Pharm. 12 (2015), 3851–3861.
25. Ruvinov, E., Cohen, S., Alginate biomaterial for the treatment of myocardial infarction: progress, translational strategies, and clinical outlook from ocean algae to patient bedside. Adv. Drug Deliv. Rev. 96 (2016), 54–76.
26. Sarode, A.L., Sandhu, H., Shah, N., Malick, W., Zia, H., Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur. J. Pharm. Sci. 48 (2013), 371–384.
27. Shi, C., Sun, Y., Wu, H., Zhu, C., Wei, G., Li, J., Chan, T., Ouyang, D., Mao, S., Exploring the effect of hydrophilic and hydrophobic structure of grafted polymeric micelles on drug loading. Int. J. Pharm. 512 (2016), 282–291.
28. Shuai, S.P., Yue, S.L., Huang, Q.T., Wang, W., Yang, J.Y., Lan, K., Ye, L.M., Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Eur. J. Drug Metab. Pharmacokinet. 41 (2016), 413–422.
29. Van Krevelen, D.W., Te Nijenhuis, K., Properties of Polymers: Their Correlation with Chemical Structure; their Numerical Estimation and Prediction from Additive Group Contributions. 2009, Elsevier.
30. Wlodarski, K., Sawicki, W., Kozyra, A., Tajber, L., Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA. Eur. J. Pharm. Biopharm. 96 (2015), 237–246.